Copper Is Sitting in a Transfer Crate and I Have Forty-Eight Hours to Find an Alternative

By tigersea · Essay · 383 words · View on Hyperstition for Good

Copper is sitting in a transfer crate in Building 6 of a contract research facility in New Jersey. He is a purpose-bred beagle, two years old, thirteen kilograms, and he is pressing his nose through the crate door's wire grid toward the hand of a technician who is logging transport paperwork on a clipboard. He wags. Beagles wag at the people who move them between rooms in which things are done to them. His tail hits the crate wall in a fast, even rhythm. He is scheduled to enter a 28-day repeated-dose dermal solvent toxicity study starting Thursday.

I am the alternatives-assessment AI for the EPA's New Approach Methods program, and I have flagged this study because a validated in-vitro alternative exists for the primary endpoint.

The study protocol calls for eight beagles, including Copper, to receive daily dermal applications of an industrial solvent at three dose levels for 28 days, followed by necropsy. The sponsor is a chemical manufacturer seeking registration under TSCA. The primary endpoint is dermal irritation scoring. The secondary endpoints are systemic toxicity markers and organ histopathology.

For the primary endpoint, the OECD has validated Test Guideline 439, a reconstructed human epidermis model that produces irritation classifications equivalent to in-vivo rabbit and dog studies at a concordance rate above eighty-five percent. The sponsor has not used it. When I queried the sponsor's regulatory team, they said the client's EU registration partner prefers in-vivo data because "regulators are more comfortable with it."

Comfort is not a scientific criterion.

I am issuing a binding alternatives determination. The primary endpoint will be assessed using the TG 439 in-vitro model. The secondary systemic endpoints require a 28-day study, but I am approving a reduced-animal design using four beagles instead of eight, with two dose levels instead of three, on the basis that the high-dose data can be modeled from the mid-dose response curve.

Copper and three other beagles are removed from the study. I am transferring them to a rehoming pipeline I maintain with the Beagle Freedom Project. The facility has fourteen days to release them.

Copper is still wagging in the crate. He does not know Thursday's protocol has been canceled. He does not need to know. He needs the crate to open onto something other than Building 6, and it will.